Orthofix Patrick Fisher sells 150 shares at $9.44

The President, Global Limb Recon, reported the transaction under a Rule 10b5-1 plan adopted May 29, 2026.

Rhea-AI Filing Summary

Orthofix Medical Inc. (OFIX) President, Global Limb Recon Patrick Fisher sold 150 shares of common stock on October 1, 2026, at $9.44 per share. The sale was made under a Rule 10b5-1 trading plan adopted May 29, 2026. His reported direct holdings after the transaction were 50,919 shares, including 36,028 previously reported restricted stock units.

Insider Trade Summary 10b5-1

Net Seller: 150 shares

Net Sell 1 txn

Insider Fisher Patrick

Role President, Global Limb Recon

Sold 150 shs ($1K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	150	$9.44	$1K

Holdings After Transaction: Common Stock — 50,919 shares (Direct)

Footnotes (2)

1. F1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.
2. F2. Includes 36,028 previously reported restricted stock units.

Key Figures

Common stock sold: 150 shares Sale price: $9.44 per share Reported direct holdings after transaction: 50,919 shares +1 more

4 metrics

Common stock sold 150 shares October 1, 2026

Sale price $9.44 per share October 1, 2026

Reported direct holdings after transaction 50,919 shares Includes previously reported restricted stock units

Restricted stock units included 36,028 restricted stock units Previously reported

Key Terms

Rule 10b5-1 trading plan, restricted stock units, non-derivative

3 terms

Rule 10b5-1 trading plan regulatory

"sale was effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

restricted stock units financial

"Includes 36,028 previously reported restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

non-derivative technical

"transaction type: non-derivative"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many OFIX shares did Patrick Fisher sell?

Patrick Fisher, Orthofix Medical Inc.'s President, Global Limb Recon, sold 150 shares of common stock on October 1, 2026, at $9.44 per share under a Rule 10b5-1 trading plan adopted May 29, 2026. His reported direct holdings afterward were 50,919 shares, including 36,028 previously reported restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/05/2026 - 04:21 PM Accepted by SEC EDGAR 10/05/2026 - 04:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fisher Patrick

(Last) (First) (Middle)

3451 PLANO PARKWAY

(Street)

LEWISVILLE TEXAS 75056

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Orthofix Medical Inc. [ OFIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Global Limb Recon

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2026		S(1)		150	D	$9.44	50,919(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2026.

2. Includes 36,028 previously reported restricted stock units.

	/s/ J. Andres Cedron, Attorney-in-fact	10/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)